Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChulalongkorn University

About this trial

Motor neuron disease (MND) is a progressive neurological disorder involving degeneration of motor neurons, leading to muscle weakness, speech and swallowing difficulties, and respiratory failure. This study aims to develop a novel treatment approach combining personalized repetitive transcranial magnetic stimulation (rTMS) with mixed reality (MR) exercise-based games (exergames) to slow disease progression and improve quality of life. In this randomised controlled trial study will compare three groups: (1) rTMS with MR exercise (personalized intervention), (2) rTMS with MR exercise (standard intervention), and (3) sham rTMS with MR exercise. Outcomes will be assessed at baseline, 3 months, and 6 months post intervention. The long-term goal is to implement this approach in clinical settings to enhance care for people with MND.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants aged between 18 and 80 years

Diagnosed with any type of motor neuron disease (MND)

Have mild to moderate severity, as assessed by the Sinaki-Mulder scale, with a severity level between 1 and 3

Disqualifiers

History of other neurological disorders, such as stroke

Use of ventilatory support

Severe dementia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Personalized rTMS

    Device

    Personalized repetitive transcranial magnetic stimulation (TMS) together with mixed-reality (MR) exercise

  • Standard rTMS

    Device

    Standard repetitive transcranial magnetic stimulation (TMS) together with mixed-reality (MR) exercise

  • Sham rTMS

    Device

    Sham rTMS together with mixed-reality (MR) exercise

Treatment groups

100 Participants
are divided into 3 treatment groups
Group A: Personalized intervention groupExperimental treatment 1 intervention
Group B: Standard intervention groupActive comparator 1 intervention
Group C: Sham groupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Amyotrophic Lateral Sclerosis Functional rating scale - revised version (ALSFRS-R)

The Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R) is a 12-item questionnaire used to assess functional ability in people with ALS across four domains: bulbar, fine motor, gross motor, and respiratory function. Each item is scored from 0 (unable) to 4 (normal), with a total score ranging from 0 to 48. It can be self-reported or clinician-administered in person, by phone, or online. Lower scores indicate greater disability. The ALSFRS-R is used to monitor disease progression and guide clinical care.

Time frame
ALSFRS-R will be measured at three time points (baseline, 3-month, and 6-month post intervention).
2

Muscle evoke potential (MEP)

Participants will be stimulated at the primary motor cortex by transcranial magnetic stimulation to measure cortical excitability, which sends the motor outputs to Tibialis Anterior (TA) and Abductor Pollicis Brevis (APB) muscles. The MEP will be used to assess muscle activity in these muscles during the stimulation. The MEP will be measured in mV.

Time frame
MEP will be mesured at three time points (baseline, 3-month, and 6-month post intervention).
3

Motor unit number estimation (MScan fit-MUNE)

For MScan fit-MUNE, CMAP is recorded at multiple stimulation intensities. The MScan fit-MUNE software then generates a curve representing the relationship between stimulation intensity and CMAP amplitude. A mathematical model is fitted to this curve to estimate the number of motor units contributing to the generation of the CMAP.

Time frame
MScan fit-MUNE will be mesured at three time points (baseline, 3-month, and 6-month post intervention).
4

Motor unit number index (MUNIX)

For MUNIX (Motor Unit Number Index), the procedure begins with recording the CMAP. Then, the participant is asked to gently contract the muscle. During this contraction, the interference pattern of muscle electrical activity is recorded. The MUNIX value is calculated by analyzing the ratio between the CMAP amplitude and the amplitude of the interference pattern. This provides an estimate of motor unit function.

Time frame
MUNIX will be measured at three time points (baseline, 3-month, and 6-month post intervention).

Secondary outcomes

1

Muscle mass

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. The muscle mass will be recored in kilograms.

Time frame
Muscle mass will be measured at three time points (baseline, 3-month, and 6-month post intervention).
2

Body mass index (BMI)

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes. The BMI will be recored in kg/m\^2.

Time frame
BMI will be measured at three time point (baseline, 3-month, 6-month post intervention).
3

Hand grip test

The Hand Grip Test is an objective measure of isometric grip strength, commonly used to assess overall muscle strength and functional status. The test is performed using a handheld dynamometer, which the participant squeezes with maximum effort, typically while seated with the elbow at a 90-degree angle. The test is usually repeated three times per hand, and the highest or average value measured in kilograms is recorded. Lower grip strength is associated with reduced physical function and is often used as an indicator of frailty, sarcopenia, or neuromuscular decline.

Time frame
Hand grip test will be measured at three time points (baseline, 3-month, and 6-month post intervention).
4

Pinch grip test

The Pinch Grip Test is used to assess the strength of the thumb muscles in individuals with motor neuron disease (MND). Participants are asked to hold a pinch grip dynamometer with their arm positioned at a 90-degree angle and squeeze as hard as possible for 3 to 5 seconds. Each set consists of 10 repetitions, and the test includes 5 sets in total, with a 1-minute rest between sets. The goal is to measure the maximum force generated during the test. Afterward, participants are instructed to maintain a pinch force at 50% ± 5% of their maximum strength for as long as possible. Results are recorded in kilograms (kg) and duration (seconds).

Time frame
Pinch grip test will be measured at three time points (baseline, 3-month, and 6-month post intervention).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chulalongkorn University

Lead sponsor

King Chulalongkorn Memorial Hospital

Collaborator